Boehringer FY oper profit up 20 pct on Pradaxa pill
FRANKFURT, April 24 (Reuters) - Boehringer Ingelheim, the world's largest unlisted drugmaker, said 2011 operating profit jumped 20 percent, boosted by sales of its anti-blood-clotting drug Pradaxa.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here